Bibliografisk note

Funding Information:
TRW has nothing to disclose. KNS has nothing to disclose. PLA has received support from Naestved, Slagelse, and Ringsted Hospitals' Research Fund and from LEO Foundation (grant no.: LF18002). LS have nothing to disclose. GBEJ has received honoraria from AbbVie, Chemocentryx, Coloplast, Incyte, Inflarx, Novartis, Pierre Fabre and UCB for participation on advisory boards, and grants from Abbvie, Astra‐Zeneca, Inflarx, Janssen‐Cilag, Leo Pharma, Novartis, Regeneron and Sanofi, for participation as an investigator, and received speaker honoraria from AbbVie, Boehringer‐Ingelheim, Galderma and MSD. He has also received unrestricted departmental grants from Abbvie, Leo Pharma and Novartis. DMLS reports personal fees from AbbVie, Janssen, Jamjoom Pharma and Sanofi, grants and personal fees from Abbvie, Leo Pharma and Novartis outside the submitted work.